Guilbault Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Guilbault Capital's ABBV Position: Q3 2026 in Review
Guilbault Capital reduced its AbbVie (ABBV) stake by 1.7% in Q3 2026, selling an estimated $10.3K and leaving 2,336 shares worth $611K. The position accounts for 0.6% of the portfolio, ranked #43.
Guilbault Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $618K in Q4 2025. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Guilbault Capital held 2,336 shares of AbbVie worth $611K as of Q3 2026.
- Guilbault Capital sold 40 AbbVie shares in Q3 2026, an estimated $10.3K.
- AbbVie made up 0.6% of Guilbault Capital's portfolio in Q3 2026, its #43 holding.
- Guilbault Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- Guilbault Capital's AbbVie position peaked at $618K in Q4 2025.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Guilbault Capital's 13F filing for Q3 2026, filed 28 Oct 2026.